Michael has been an entrepreneur for over 20 years. In 2004, Michael co-founded MIG Verwaltungs-AG, and as a member of the Board of Management he is Head of the participations division. MIG AG is a management company for various VC funds which are financed by private investors and which invest in companies in Germany and Austria, mainly in the life science and high-tech fields. Major biotech investments include BioNTech, Immatics and AFFiRiS. Recent exits include the €200m disposal of Suppremol to Baxalta and the €422m disposal of Ganymed Pharmaceuticals to Astellas.